Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-16-007755
Filing Date
2016-08-09
Accepted
2016-08-09 13:39:25
Documents
80
Period of Report
2016-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q arlz-20160630x10q.htm 10-Q 1549307
2 EX-31.1 arlz-20160630ex311fa9cc8.htm EX-31.1 15223
3 EX-31.2 arlz-20160630ex3129b08fd.htm EX-31.2 19137
4 EX-32.1 arlz-20160630ex321cf29e7.htm EX-32.1 11032
5 EX-32.2 arlz-20160630ex3224e5b8f.htm EX-32.2 11095
  Complete submission text file 0001558370-16-007755.txt   7384658

Data Files

Seq Description Document Type Size
6 EX-101.INS arlz-20160630.xml EX-101.INS 1620219
7 EX-101.SCH arlz-20160630.xsd EX-101.SCH 60228
8 EX-101.CAL arlz-20160630_cal.xml EX-101.CAL 68108
9 EX-101.DEF arlz-20160630_def.xml EX-101.DEF 224293
10 EX-101.LAB arlz-20160630_lab.xml EX-101.LAB 551371
11 EX-101.PRE arlz-20160630_pre.xml EX-101.PRE 424911
Mailing Address 7100 WEST CREDIT AVENUE, SUITE 101 MISSISSAUGA A6 L5N 0E4
Business Address 7100 WEST CREDIT AVENUE, SUITE 101 MISSISSAUGA A6 L5N 0E4 905-876-1118
Aralez Pharmaceuticals Inc. (Filer) CIK: 0001660719 (see all company filings)

EIN.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37691 | Film No.: 161817201
SIC: 2834 Pharmaceutical Preparations